PMA

P100014: SOLESTA INJECTABLE GEL

FDA PMA · AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE · Palette Life Sciences

Key facts

PMA number P100014
Trade name SOLESTA INJECTABLE GEL
Generic name AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE
Applicant Palette Life Sciences
Owner/operator Palette Life Sciences
Product code LNM
Approval date May 27, 2011
Docket number 11M-0445
Notice date Jun 15, 2011
Establishment registration 3014909464
FEI number 3014909464

At a glance

  • 10–99 Supplements
  • Dec 7, 2023 Latest supplement decision
  • No Withdrawn
  • Yes Summary of safety and effectiveness on file
  • 1–9 UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals